Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23651417)

1.

Waldenström macroglobulinaemia: the key questions.

D'Souza A, Ansell S, Reeder C, Gertz MA.

Br J Haematol. 2013 Aug;162(3):295-303. doi: 10.1111/bjh.12367. Epub 2013 May 8. Review.

PMID:
23651417
2.

Waldenström macroglobulinaemia.

Ghobrial IM, Gertz MA, Fonseca R.

Lancet Oncol. 2003 Nov;4(11):679-85. Review.

PMID:
14602248
3.

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.

Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, Morice WG, Bergsagel PL, Buadi FK, Colgan JP, Dingli D, Dispenzieri A, Greipp PR, Habermann TM, Hayman SR, Inwards DJ, Johnston PB, Kumar SK, Lacy MQ, Lust JA, Markovic SN, Micallef IN, Nowakowski GS, Porrata LF, Roy V, Russell SJ, Short KE, Stewart AK, Thompson CA, Witzig TE, Zeldenrust SR, Dalton RJ, Rajkumar SV, Gertz MA.

Mayo Clin Proc. 2010 Sep;85(9):824-33. doi: 10.4065/mcp.2010.0304. Epub 2010 Aug 11. Review.

4.

Waldenström macroglobulinaemia.

Fonseca R, Hayman S.

Br J Haematol. 2007 Sep;138(6):700-20. Epub 2007 Aug 2. Review.

PMID:
17672883
5.

Current treatment options for Waldenström macroglobulinemia.

Vijay A, Gertz MA.

Clin Lymphoma Myeloma. 2008 Aug;8(4):219-29. doi: 10.3816/CLM.2008.n.029. Review.

PMID:
18765309
6.

Waldenström macroglobulinemia.

Gertz MA.

Hematology. 2012 Apr;17 Suppl 1:S112-6. doi: 10.1179/102453312X13336169156212.

PMID:
22507796
7.

Waldenström's macroglobulinemia.

Dimopoulos MA, Anagnostopoulos A.

Best Pract Res Clin Haematol. 2005;18(4):747-65. Review.

PMID:
16026748
8.

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD, Devine S, Djulbegovic B, Faber EA Jr, Gasparetto C, Hernandez-Ilizaliturri F, Huff CA, Kassim A, Krishnan AY, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F, Kumar R, Shead DA; NCCN (National Comprehensive Cancer Network).

J Natl Compr Canc Netw. 2012 Oct 1;10(10):1211-9.

PMID:
23054875
9.

Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.

Vitolo U, Ferreri AJ, Montoto S.

Crit Rev Oncol Hematol. 2008 Aug;67(2):172-85. doi: 10.1016/j.critrevonc.2008.03.008. Epub 2008 May 21. Review.

PMID:
18499469
10.

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.

Owen RG, Pratt G, Auer RL, Flatley R, Kyriakou C, Lunn MP, Matthey F, McCarthy H, McNicholl FP, Rassam SM, Wagner SD, Streetly M, D'Sa S; British Committee for Standards in Haematology.

Br J Haematol. 2014 May;165(3):316-33. doi: 10.1111/bjh.12760. Epub 2014 Feb 15. No abstract available.

PMID:
24528152
11.

Prognosis and treatment of Waldenström's macroglobulinemia.

Louw VJ, Webb MJ.

Transfus Apher Sci. 2010 Apr;42(2):193-7. doi: 10.1016/j.transci.2010.01.017. Epub 2010 Feb 8. Review.

PMID:
20117052
12.

Are you sure this is Waldenstrom macroglobulinemia?

Ghobrial IM.

Hematology Am Soc Hematol Educ Program. 2012;2012:586-94. doi: 10.1182/asheducation-2012.1.586. Review.

13.

Risk stratification in Waldenström macroglobulinemia.

Morel P, Merlini G.

Expert Rev Hematol. 2012 Apr;5(2):187-99. doi: 10.1586/ehm.11.82. Review.

PMID:
22475287
14.

Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.

Dimopoulos MA, Gertz MA, Kastritis E, Garcia-Sanz R, Kimby EK, Leblond V, Fermand JP, Merlini G, Morel P, Morra E, Ocio EM, Owen R, Ghobrial IM, Seymour J, Kyle RA, Treon SP.

J Clin Oncol. 2009 Jan 1;27(1):120-6. doi: 10.1200/JCO.2008.17.7865. Epub 2008 Dec 1. Review.

PMID:
19047284
15.

Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.

Mullen EC, Wang M.

Clin J Oncol Nurs. 2007 Feb;11(1):87-95. Review.

PMID:
17441400
16.

Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases.

García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF; Spanish Group for the Study of Waldenström Macroglobulinaemia and PETHEMA (Programme for the Study and Treatment of Haematological Malignancies).

Br J Haematol. 2001 Dec;115(3):575-82. Review.

PMID:
11736938
17.

Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.

Owen RG, Johnson SA, Morgan GJ.

Hematol Oncol. 2000 Jun;18(2):41-9. Review. No abstract available.

PMID:
10960874
18.

Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.

Yamamoto R, Takaori-Kondo A, Kanda J, Imada K, Ichinohe T, Ishikawa T, Ohmori K, Uchiyama T.

Bone Marrow Transplant. 2008 Mar;41(6):591-3. Epub 2007 Dec 10. No abstract available.

PMID:
18071292
19.

Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Weber D, Treon SP, Emmanouilides C, Branagan AR, Byrd JC, Bladé J, Kimby E.

Semin Oncol. 2003 Apr;30(2):127-31. Review.

PMID:
12720121
20.

Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.

Naderi N, Yang DT.

Arch Pathol Lab Med. 2013 Apr;137(4):580-5. doi: 10.5858/arpa.2012-0034-RS. Review.

PMID:
23544948
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk